Atlas Trials

Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies

Clinical trial NCT00703170 · COMPLETED

Trial details

NCT number
NCT00703170
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Resistant Solid Malignancies
Start date
2008-03-01
Primary completion
2011-06-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.